GE HealthCare Technologies GEHC Product — Cost of Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by GE HealthCare Technologies in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about GE HealthCare Technologies's product — cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is GE HealthCare Technologies's product — cost of sales?
- GE HealthCare Technologies (GEHC) reported product — cost of sales of $2.28B in Q1 2026.
- How has GE HealthCare Technologies's product — cost of sales changed year-over-year?
- GE HealthCare Technologies's product — cost of sales increased by 16.3% year-over-year, from $1.96B to $2.28B.
- What is the long-term trend for GE HealthCare Technologies's product — cost of sales?
- Over 4 years (2021 to 2025), GE HealthCare Technologies's product — cost of sales has grown at a 5.6% compound annual growth rate (CAGR), from $7.2B to $8.94B.
- What does product — cost of sales mean?
- Includes the direct costs attributable to the production and delivery of medical equipment, such as raw materials, direct labor, and manufacturing overhead. Monitoring this metric helps assess the efficiency of the supply chain and the impact of inflationary pressures on product margins.